306 related articles for article (PubMed ID: 27115168)
21. Biology and management of histologic transformation of indolent lymphoma.
Freedman AS
Hematology Am Soc Hematol Educ Program; 2005; ():314-20. PubMed ID: 16304397
[TBL] [Abstract][Full Text] [Related]
22. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
Wang W; Hu S; Lu X; Young KH; Medeiros LJ
Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391
[TBL] [Abstract][Full Text] [Related]
23. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
24. MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implications.
Sewastianik T; Prochorec-Sobieszek M; Chapuy B; Juszczyński P
Biochim Biophys Acta; 2014 Dec; 1846(2):457-67. PubMed ID: 25199984
[TBL] [Abstract][Full Text] [Related]
25. Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
Din L; Sheikh M; Kosaraju N; Smedby KE; Bernatsky S; Berndt SI; Skibola CF; Nieters A; Wang S; McKay JD; Cocco P; Maynadié M; Foretová L; Staines A; Mack TM; de Sanjosé S; Vyse TJ; Padyukov L; Monnereau A; Arslan AA; Moore A; Brooks-Wilson AR; Novak AJ; Glimelius B; Birmann BM; Link BK; Stewart C; Vajdic CM; Haioun C; Magnani C; Conti DV; Cox DG; Casabonne D; Albanes D; Kane E; Roman E; Muzi G; Salles G; Giles GG; Adami HO; Ghesquières H; De Vivo I; Clavel J; Cerhan JR; Spinelli JJ; Hofmann J; Vijai J; Curtin K; Costenbader KH; Onel K; Offit K; Teras LR; Morton L; Conde L; Miligi L; Melbye M; Ennas MG; Liebow M; Purdue MP; Glenn M; Southey MC; Din M; Rothman N; Camp NJ; Wong Doo N; Becker N; Pradhan N; Bracci PM; Boffetta P; Vineis P; Brennan P; Kraft P; Lan Q; Severson RK; Vermeulen RCH; Milne RL; Kaaks R; Travis RC; Weinstein SJ; Chanock SJ; Ansell SM; Slager SL; Zheng T; Zhang Y; Benavente Y; Taub Z; Madireddy L; Gourraud PA; Oksenberg JR; Cozen W; Hjalgrim H; Khankhanian P
Genet Epidemiol; 2019 Oct; 43(7):844-863. PubMed ID: 31407831
[TBL] [Abstract][Full Text] [Related]
26. Non-Hodgkin and Hodgkin Lymphomas Select for Overexpression of BCLW.
Adams CM; Mitra R; Gong JZ; Eischen CM
Clin Cancer Res; 2017 Nov; 23(22):7119-7129. PubMed ID: 28855351
[No Abstract] [Full Text] [Related]
27. Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies.
Hernández-Verdin I; Labreche K; Benazra M; Mokhtari K; Hoang-Xuan K; Alentorn A
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374413
[TBL] [Abstract][Full Text] [Related]
28. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.
Wang SS; Davis S; Cerhan JR; Hartge P; Severson RK; Cozen W; Lan Q; Welch R; Chanock SJ; Rothman N
Carcinogenesis; 2006 Sep; 27(9):1828-34. PubMed ID: 16543247
[TBL] [Abstract][Full Text] [Related]
30. Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.
Morton LM; Sampson JN; Cerhan JR; Turner JJ; Vajdic CM; Wang SS; Smedby KE; de Sanjosé S; Monnereau A; Benavente Y; Bracci PM; Chiu BC; Skibola CF; Zhang Y; Mbulaiteye SM; Spriggs M; Robinson D; Norman AD; Kane EV; Spinelli JJ; Kelly JL; La Vecchia C; Dal Maso L; Maynadié M; Kadin ME; Cocco P; Costantini AS; Clarke CA; Roman E; Miligi L; Colt JS; Berndt SI; Mannetje A; de Roos AJ; Kricker A; Nieters A; Franceschi S; Melbye M; Boffetta P; Clavel J; Linet MS; Weisenburger DD; Slager SL
J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):1-14. PubMed ID: 25174022
[TBL] [Abstract][Full Text] [Related]
31. Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.
Rohde M; Bonn BR; Zimmermann M; Lange J; Möricke A; Klapper W; Oschlies I; Szczepanowski M; Nagel I; Schrappe M; ; ; Loeffler M; Siebert R; Reiter A; Burkhardt B
Haematologica; 2017 Jun; 102(6):1091-1098. PubMed ID: 28209658
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.
Mihăilă RG
World J Gastroenterol; 2016 Jul; 22(27):6214-23. PubMed ID: 27468211
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management.
Peveling-Oberhag J; Arcaini L; Hansmann ML; Zeuzem S
J Hepatol; 2013 Jul; 59(1):169-77. PubMed ID: 23542089
[TBL] [Abstract][Full Text] [Related]
34. Aggressive B-cell lymphomas: frequency, immunophenotype, and genetics in a reference laboratory population.
Naeini YB; Wu A; O'Malley DP
Ann Diagn Pathol; 2016 Dec; 25():7-14. PubMed ID: 27806850
[TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of non-Hodgkin's lymphoma.
Nogai H; Dörken B; Lenz G
J Clin Oncol; 2011 May; 29(14):1803-11. PubMed ID: 21483013
[TBL] [Abstract][Full Text] [Related]
36. Clinical Applications of the Genomic Landscape of Aggressive Non-Hodgkin Lymphoma.
Moffitt AB; Dave SS
J Clin Oncol; 2017 Mar; 35(9):955-962. PubMed ID: 28297626
[TBL] [Abstract][Full Text] [Related]
37. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
[TBL] [Abstract][Full Text] [Related]
38. Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.
Fernberg P; Chang ET; Duvefelt K; Hjalgrim H; Eloranta S; Sørensen KM; Porwit A; Humphreys K; Melbye M; Ekström Smedby K
Cancer Causes Control; 2010 May; 21(5):759-69. PubMed ID: 20087644
[TBL] [Abstract][Full Text] [Related]
39. Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis.
Jardin F; Sahota SS
Hematology; 2005 Apr; 10(2):115-29. PubMed ID: 16019457
[TBL] [Abstract][Full Text] [Related]
40. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Iqbal J; Naushad H; Bi C; Yu J; Bouska A; Rohr J; Chao W; Fu K; Chan WC; Vose JM
Blood Rev; 2016 Mar; 30(2):73-88. PubMed ID: 26432520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
